JPWO2021010349A1 - - Google Patents

Info

Publication number
JPWO2021010349A1
JPWO2021010349A1 JP2021533054A JP2021533054A JPWO2021010349A1 JP WO2021010349 A1 JPWO2021010349 A1 JP WO2021010349A1 JP 2021533054 A JP2021533054 A JP 2021533054A JP 2021533054 A JP2021533054 A JP 2021533054A JP WO2021010349 A1 JPWO2021010349 A1 JP WO2021010349A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021533054A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021010349A1 publication Critical patent/JPWO2021010349A1/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38—Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2021533054A 2019-07-12 2020-07-10 Pending JPWO2021010349A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019129798 2019-07-12
PCT/JP2020/027144 WO2021010349A1 (ja) 2019-07-12 2020-07-10 非アルコール性脂肪肝炎の血中線維化マーカーの開発

Publications (1)

Publication Number Publication Date
JPWO2021010349A1 true JPWO2021010349A1 (ja) 2021-01-21

Family

ID=74209901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021533054A Pending JPWO2021010349A1 (ja) 2019-07-12 2020-07-10

Country Status (5)

Country Link
US (1) US20230236194A1 (ja)
EP (1) EP3998478A4 (ja)
JP (1) JPWO2021010349A1 (ja)
CN (1) CN114364985A (ja)
WO (1) WO2021010349A1 (ja)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4207283B2 (ja) * 1998-02-03 2009-01-14 和光純薬工業株式会社 胎児染色体異常の判別方法
JPWO2009069776A1 (ja) * 2007-11-30 2011-04-21 国立大学法人北海道大学 糖鎖分析による肝疾患の診断方法
WO2013057078A1 (en) * 2011-10-19 2013-04-25 Roche Glycart Ag Separation method for fucosylated antibodies
JP2017502307A (ja) * 2014-01-08 2017-01-19 李▲錚▼ 唾液の糖タンパク質糖鎖に基づいて肝疾患を識別するレクチンチップ及びその使用
JP6545960B2 (ja) * 2014-02-27 2019-07-17 シスメックス株式会社 標的物質の検出用試薬、検出方法および標的物質を検出するために用いられる担体ならびにその製造方法
US11181527B2 (en) * 2015-08-26 2021-11-23 Vib Vzw Means and methods for monitoring inflammation
JPWO2017126514A1 (ja) 2016-01-19 2018-12-20 塩野義製薬株式会社 非アルコール性脂肪肝炎検出方法
JP6893406B2 (ja) * 2016-10-19 2021-06-23 日本化薬株式会社 Ｎａｓｈやｎａｆｌｄの進展度の検査方法及び炎症疾患や癌の検査方法
JP2019129798A (ja) 2018-02-02 2019-08-08 東ソー株式会社 加熱サンプルを用いたより迅速で効率的な等温増幅反応
JP7239139B2 (ja) * 2018-08-03 2023-03-14 国立大学法人金沢大学 肝硬変の診断方法、非アルコール性脂肪肝炎及び肝細胞がんの合併症の診断方法並びに非アルコール性脂肪肝炎及び食道胃静脈瘤の合併症の診断方法

Also Published As

Publication number Publication date
US20230236194A1 (en) 2023-07-27
WO2021010349A1 (ja) 2021-01-21
CN114364985A (zh) 2022-04-15
EP3998478A4 (en) 2023-08-09
EP3998478A1 (en) 2022-05-18

Similar Documents

Publication Publication Date Title
BR112021017339A2 (ja)
BR112021018450A2 (ja)
BR112021013854A2 (ja)
BR112021017939A2 (ja)
BR112021017892A2 (ja)
BR112021017782A2 (ja)
BR112021018168A2 (ja)
BR112021017728A2 (ja)
BR112021018452A2 (ja)
BR112021017355A2 (ja)
BR112021017703A2 (ja)
BR112021018102A2 (ja)
BR112021018584A2 (ja)
BR112021017637A2 (ja)
BR112021015080A2 (ja)
BR112021012348A2 (ja)
BR112021018250A2 (ja)
BR112021018084A2 (ja)
BR112021018093A2 (ja)
BR112021013944A2 (ja)
BR112021013128A2 (ja)
BR112021018484A2 (ja)
BR112021017732A2 (ja)
BR112021017949A2 (ja)
BR112021017983A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230529